Zero chance we go it alone. Maybe if we were entering virgin territory but there's two very well established players with lots of money. Plus the fact newer investors probably in it for a quick buck compared to those loyally holding since vaccine days (accustomed to waiting for something to happen). I've held for 7 years so what's another few years.
Be interesting if WP can flog off the aortic valve business unit and keep ADAPT for other projects.
AVR Price at posting:
$24.50 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)